Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Shares Issued (2018 - 2025)

Organogenesis Holdings has reported Shares Issued over the past 7 years, most recently at $2000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 99.81% year-over-year to $2000.0; the TTM value through Dec 2025 reached $157000.0, down 87.41%, while the annual FY2025 figure was $157000.0, 87.41% down from the prior year.
  • Shares Issued for Q4 2025 was $2000.0 at Organogenesis Holdings, down from $130000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $1.8 million in Q2 2022 and troughed at $2000.0 in Q4 2025.
  • A 4-year average of $436307.7 and a median of $180000.0 in 2024 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 3150.0% in 2025 and fell as far as 99.81% in 2025.
  • Year by year, Shares Issued stood at $83000.0 in 2021, then plummeted by 66.27% to $28000.0 in 2022, then surged by 3696.43% to $1.1 million in 2024, then plummeted by 99.81% to $2000.0 in 2025.
  • Business Quant data shows Shares Issued for ORGO at $2000.0 in Q4 2025, $130000.0 in Q3 2025, and $25000.0 in Q1 2025.